Money Talks: Why weight-loss drugs will resha...

Join The Economist’s Mike Bird, Alice Fulwood and Ethan Wu for award-winning reporting and discussion on the stories that move markets. They speak to top bosses, investors and analysts around the world for unmatched insight into global finance, business and economics. Published e ...  Show more

After months of bluster, he’s finally done it. At a ceremony in the White House Rose Garden, Donald Trump overturned decades of American trade policy with a simple signature. The new wave of <a href="https://www.economist.com/finance-and-economics/2025/04/03/trump-takes-americ ...

On Monday, President Donald Trump signed an executive order telling drugmakers to slash the prices of their medicines. Once again, the president showed an amazing nose for interesting questions. Statistically, the U.S. accounts for 4 percent of the world’s population but nearly 5 ...  Show more

Drugs in America often cost more than three times as much as those elsewhere. But Donald Trump’s plan to cut prescription costs and impose tariffs may have unintended consequences for consumers. Inside North Korea’s crypto-heist: from hermit kingdom to hacking kingdom (10:45). An ...  Show more

Drugs in America often cost more than three times as much as those elsewhere. But Donald Trump’s plan to <a href="https://www.economist.com/business/2025/05/13/big-pharmas-jumbo-profits-are-under-threat-in-america?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theint ...

Snack-food companies have long shown their adaptability to changing diets. How could the rise of appetite-suppressing drugs and fears about ultra-processed foods change the food we consume? How hearing aids and other lifestyle choices can reduce your risk of dementia (11:00). And ...  Show more